Workflow
中国脑卒中药物行业市场规模测算逻辑模型 头豹词条报告系列
头豹研究院·2024-11-04 12:01

Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - The Chinese stroke medication market is projected to grow significantly, with a market size of 1,089.48 billion RMB in 2023, expected to reach 2,826.67 billion RMB by 2027, reflecting a compound annual growth rate (CAGR) of approximately 26.43% from 2022 to 2023 and maintaining similar growth rates in subsequent years [17][18] - The number of stroke patients in China is estimated to increase from 1,236.76 million in 2018 to 2,106.94 million by 2027, indicating a steady growth trend [27] - The average annual medication cost for stroke patients is projected to rise from 0.62 million RMB in 2018 to 2.58 million RMB by 2027, with a consistent growth rate of around 17% annually [32][34] - The penetration rate of stroke medications is expected to increase from 43% in 2018 to 52% by 2027, suggesting a gradual improvement in treatment access [35] Summary by Sections 1. Market Size - The Chinese stroke medication market size is calculated based on the total population, stroke prevalence rate, average medication cost, and medication penetration rate [15][17] - The market size in billion RMB for the years 2018 to 2027 is as follows: 329.72, 421.21, 534.73, 682.29, 861.72, 1,089.48, 1,389.41, 1,754.29, 2,238.71, and 2,826.67 respectively [17] 2. Population Data - The total population of China is projected to grow from 1,405.41 million in 2018 to 1,433.29 million by 2027, with a compound annual growth rate of approximately 0.3% [20] 3. Stroke Prevalence Rate - The stroke prevalence rate is expected to rise from 0.88% in 2018 to 1.47% by 2027, indicating an increasing trend in stroke incidence [24][26] 4. Stroke Patient Numbers - The number of stroke patients is projected to increase from 1,236.76 million in 2018 to 2,106.94 million by 2027, reflecting a steady growth in the patient population [27] 5. Average Medication Costs - The average annual medication cost for stroke patients is expected to increase from 0.62 million RMB in 2018 to 2.58 million RMB by 2027, with consistent annual growth rates around 17% [32][34] 6. Medication Penetration Rate - The penetration rate of stroke medications is projected to grow from 43% in 2018 to 52% by 2027, indicating an improvement in treatment access and utilization [35]